ERO vs EXK
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ERO presents a high-growth profile with a Piotroski F-Score of 4/9, indicating stable but not strong financial health. While the current price of $27.31 trades at a premium to the Graham Number ($22.61) and Intrinsic Value ($17.71), this is justified by explosive revenue growth (161.30% YoY) and a very attractive forward P/E of 6.17. The company exhibits exceptional profitability with an ROE of 34.91% and operating margins of 43.60%, significantly outperforming sector averages. Despite liquidity concerns reflected in a low quick ratio, the fundamental growth trajectory and analyst targets suggest continued upside.
Endeavour Silver Corp. presents a stark contrast between explosive top-line growth and deteriorating fundamental health, evidenced by a weak Piotroski F-Score of 2/9. While revenue growth is exceptional at 309.20% YoY and analysts maintain a 'strong_buy' rating with a target of $16.17, the company suffers from negative profit margins (-25.48%) and a consistent failure to meet earnings estimates (0/4 beats in the last year). The stock is currently trading at a high Price/Book multiple (4.92), suggesting a premium valuation that is not yet supported by bottom-line stability. The overall outlook is neutral as the bullish commodity-driven analyst sentiment clashes with severe deterministic health warnings.
Compare Another Pair
Related Comparisons
ERO vs EXK: Head-to-Head Comparison
This page compares Ero Copper Corp. (ERO) and Endeavour Silver Corp. (EXK) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.